UKAD has produced specific guidelines and resources for a number of common medical conditions requiring a Therapeutic Use Exemption (TUE).
Athletes who are applying for a TUE for one of the medical conditions below must complete the relevant application form and fulfil all requirements outlined in the relevant guidance documents.
Athletes who are prescribed an adrenaline auto-injector for use in emergency situations (such as an allergic reaction) should refer to the following guidelines:
Athletes requiring a TUE for a prohibited substance to treat asthma (including acute exacerbations of asthma) should refer to the following documentation:
Beta-2 agonist TUE application form (for specific inhalers)
Standard TUE application form (for acute exacerbations of asthma)
Athletes requiring a TUE for stimulant medication to treat attention deficit hyperactivity disorder (ADHD) should refer to the following documentation:
Athletes requiring a TUE for the use of insulins to treat diabetes should refer to the following documentation:
In the course of emergency treatment (e.g. surgery or admission to A&E), athletes may be prescribed with medication or methods of administration which are prohibited in sport. Please refer to the following resource to find out when a TUE is necessary in such circumstances:
Athletes requiring a TUE for the use of a glucocorticoid should refer to the following resources to find out when a TUE is necessary and the medical evidence required to support an application:
Glucocorticoid TUE Policy (the policy is effective from 01 January 2022)
Glucocorticoid TUE Policy Infographic (to be launched at the end of October 2021)
Glucocorticoid pre-application checklist and TUE application form (for local injections only)
Standard TUE application form (for glucocorticoids administered by a systemic route)
Athletes who are prescribed a systemic glucocorticoid (such as an intramuscular triamcinolone injection) to treat hay fever should refer to the following documentation:
Please note: Applications for the one-off use of an intramuscular glucocorticoid (such as triamcinolone) must be submitted in advance of commencing treatment and the injection should not be administered until a decision has been communicated by UKAD to the athlete requesting a TUE.